Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of the Human IL33 Polymorphism rs1929992 (T > C) with Sanger Sequencing Validation Authors: Aléia Harumi Uchibaba Yamanaka, Guilherme Castellani, Matheus Braga, Josiane Bazzo de Alencar, Letícia Cristina de Almeida Silva, Quirino Alves de Lima Neto Published: 2026 ABSTRACT AbstractSingle‐nucleotide polymorphisms (SNPs) may influence gene expression and contribute to interindividual variability in immune responses and disease susceptibility. Interleukin‐33 (IL33), a cytokine involved in inflammation, immune regulation, epithelial barrier homeostasis, and tissue remodeling, has been implicated in allergic, autoimmune, inflammatory, and neoplastic disorders. The IL33 rs1929992 (T > C) polymorphism, located in intron 3, has been associated with altered IL33 expression, with the T allele linked to increased cytokine production compared with the C allele. This article describes a standardized sequence‐specific primer polymerase chain reaction (PCR‐SSP) protocol for genotyping the human IL33 rs1929992 polymorphism, with validation by Sanger sequencing. The protocol includes optimization of annealing temperature, MgCl2 concentration, primer balance, deoxynucleotide triphosphates (dNTPs), and DNA input to ensure amplification specificity and reproducibility. Allele‐specific amplification is achieved using forward primers specific for the T and C alleles in independent reactions and analyzed by agarose gel electrophoresis, with the human growth hormone (HGH) gene used as an internal control. This protocol provides a simple, reproducible, and accessible method for rs1929992 genotyping, suitable for population‐based and genetic association studies involving immune‐mediated and inflammatory diseases. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: PCR‐SSP genotyping of IL33 rs1929992 Support Protocol 1: Extraction of genomic DNA by salting‐out Introduction Interleukin‐33 (IL33) is a member of the IL‐1 cytokine family that functions as an alarmin released upon tissue injury or cellular stress, contributing to the regulation of innate and adaptive immune responses. Through signaling via the ST2 receptor, IL33 participates in epithelial barrier maintenance, inflammation, tissue remodeling, and type 2 immunity and has been implicated in the pathogenesis of allergic, autoimmune, inflammatory, and neoplastic diseases. Genetic variation within the IL33 gene may influence cytokine expression and modify disease susceptibility. Among these variants, the rs1929992 (T > C) single‐nucleotide polymorphism (SNP), located in intron 3 of IL33, has been associated with altered IL33 expression, with studies suggesting greater cytokine production in carriers of the T allele compared with the C allele. Despite its analytical accuracy, Sanger sequencing may be impractical for routine genotyping in large sample collections because of labor requirements, turnaround time, and per‐sample cost. Alternative approaches, including TaqMan allelic discrimination assays and high‐resolution melting (HRM) analysis, may improve throughput but generally rely on fluorescence‐based chemistry, real‐time PCR systems, or specialized melting‐analysis platforms that are not universally available in conventional molecular laboratories. In contrast, sequence‐specific primer polymerase chain reaction (PCR‐SSP) enables SNP discrimination through conventional end‐point PCR followed by agarose gel electrophoresis. Previous applications of PCR‐SSP for immune‐related SNP genotyping further support the feasibility of this strategy in standard molecular biology laboratories (Castellani et al., 2026). PCR‐SSP is based on allele‐selective amplification, in which primer extension occurs only when the 3′‐terminal nucleotide is complementary to the target sequence. For IL33 rs1929992, allele‐specific forward primers targeting the T and C variants are used in independent reactions together with a common reverse primer, enabling selective detection of each allele. After agarose gel electrophoresis, genotype assignment is determined by the amplification profile: amplification exclusively in the T‐specific reaction indicates a T/T genotype, amplification exclusively in the C‐specific reaction indicates a C/C genotype, and amplification in both reactions identifies heterozygous T/C samples. Basic Protocol 1 describes allele‐specific amplification and genotype determination of rs1929992, and Support Protocol 1 details genomic DNA extraction by salting‐out. PCR‐SSP GENOTYPING OF IL33 rs1929992 This protocol describes a sequence‐specific primer polymerase chain reaction (PCR‐SSP) approach for genotyping the human IL33 polymorphism rs1929992 (T > C). Each sample is analyzed using two independent amplification reactions containing allele‐specific forward primers designed to selectively detect either the T or C variant (F3.1 for T and F3.2 for C), together with a common reverse primer (R3). Allele discrimination is achieved by positioning the variant nucleotide at the 3′ terminus of the allele‐specific forward primer, allowing amplification only when complete complementarity with the target allele is present. A fragment of the human growth hormone (HGH) gene is coamplified as an internal control to verify amplification efficiency. Under optimized reaction conditions, the assay produces a distinct allele‐specific 155‐bp fragment together with the internal control band upon agarose gel electrophoresis, enabling reliable discrimination between homozygous and heterozygous genotypes. Materials 2% sodium hypochlorite70% (w/v) ethanolH2O, nuclease‐free5 U/µl Taq DNA polymerase, recombinant (Invitrogen, cat. no. 10342020), supplied with 10× PCR buffer (200 mM Tris·Cl, pH 8.4/500 mM KCl) and 50 mM MgCl2 (store at −20°C)dNTP mix (Thermo Fisher Scientific, cat. no. R0181, or equivalent) TLR9 primers (see Table 1) HGH primers (see Table 1)Genomic DNA (30‐50 ng/µl; see Support Protocol 1)Reagents for gel electrophoresis: Agarose (Invitrogen, cat. no. 16500500, or equivalent)SYBR Safe DNA gel stain (Invitrogen, cat. no. S33102)10× Tris/borate/EDTA (TBE) buffer (Thermo Fisher Scientific, cat. no. B52, or equivalent)DNA ladder, 100 bp (GeneRuler 100 bp DNA ladder, Thermo Fisher Scientific, cat. no. SM0241)5× loading dye (Promega, cat. no. G190A, or equivalent) Dedicated hood for PCR2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tips0.2‐ml PCR tubes or stripsThermal cycler (e.g., Veriti 96‐Well Fast Thermal Cycler, or equivalent)Agarose gel electrophoresis apparatusGel documentation system 2% sodium hypochlorite 2% sodium hypochlorite 70% (w/v) ethanol 70% (w/v) ethanol H2O, nuclease‐free H2O, nuclease‐free 5 U/µl Taq DNA polymerase, recombinant (Invitrogen, cat. no. 10342020), supplied with 10× PCR buffer (200 mM Tris·Cl, pH 8.4/500 mM KCl) and 50 mM MgCl2 (store at −20°C) 5 U/µl Taq DNA polymerase, recombinant (Invitrogen, cat. no. 10342020), supplied with 10× PCR buffer (200 mM Tris·Cl, pH 8.4/500 mM KCl) and 50 mM MgCl2 (store at −20°C) dNTP mix (Thermo Fisher Scientific, cat. no. R0181, or equivalent) dNTP mix (Thermo Fisher Scientific, cat. no. R0181, or equivalent) TLR9 primers (see Table 1) TLR9 primers (see Table 1) HGH primers (see Table 1) HGH primers (see Table 1) Genomic DNA (30‐50 ng/µl; see Support Protocol 1) Genomic DNA (30‐50 ng/µl; see Support Protocol 1) Reagents for gel electrophoresis: Agarose (Invitrogen, cat. no. 16500500, or equivalent)SYBR Safe DNA gel stain (Invitrogen, cat. no. S33102)10× Tris/borate/EDTA (TBE) buffer (Thermo Fisher Scientific, cat. no. B52, or equivalent)DNA ladder, 100 bp (GeneRuler 100 bp DNA ladder, Thermo Fisher Scientific, cat. no. SM0241)5× loading dye (Promega, cat. no. G190A, or equivalent) Reagents for gel electrophoresis: Agarose (Invitrogen, cat. no. 16500500, or equivalent) Agarose (Invitrogen, cat. no. 16500500, or equivalent) SYBR Safe DNA gel stain (Invitrogen, cat. no. S33102) SYBR Safe DNA gel stain (Invitrogen, cat. no. S33102) 10× Tris/borate/EDTA (TBE) buffer (Thermo Fisher Scientific, cat. no. B52, or equivalent) 10× Tris/borate/EDTA (TBE) buffer (Thermo Fisher Scientific, cat. no. B52, or equivalent) DNA ladder, 100 bp (GeneRuler 100 bp DNA ladder, Thermo Fisher Scientific, cat. no. SM0241) DNA ladder, 100 bp (GeneRuler 100 bp DNA ladder, Thermo Fisher Scientific, cat. no. SM0241) 5× loading dye (Promega, cat. no. G190A, or equivalent) 5× loading dye (Promega, cat. no. G190A, or equivalent) Dedicated hood for PCR Dedicated hood for PCR 2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tips 2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tips 0.2‐ml PCR tubes or strips 0.2‐ml PCR tubes or strips Thermal cycler (e.g., Veriti 96‐Well Fast Thermal Cycler, or equivalent) Thermal cycler (e.g., Veriti 96‐Well Fast Thermal Cycler, or equivalent) Agarose gel electrophoresis apparatus Agarose gel electrophoresis apparatus Gel documentation system Gel documentation system Table 1PrimersPrimersSequence (5′→ 3′)Amplicon (pb)Forward F3.1CATTTTCCCCCCAAATTTCAATForward F3.2CATTTTCCCCCCAAATTTCAAC155Reverse R3AAGTCATCATCAACTTGGAACC HGH‐FTGCCTTCCCAACCATTCCCTTA460 HGH‐RTCACGGATTTCTGTTGTCTTTCJohn Wiley & Sons, Ltd. Primers 1Decontaminate the PCR workspace and pipets using 2% sodium hypochlorite followed by 70% ethanol. Avoid direct application of hypochlorite to glass surfaces. Decontaminate the PCR workspace and pipets using 2% sodium hypochlorite followed by 70% ethanol. Avoid direct application of hypochlorite to glass surfaces. 2Expose the PCR hood to ultraviolet light for 20 min before reaction setup. Expose the PCR hood to ultraviolet light for 20 min before reaction setup. 3Label 0.2‐ml PCR tubes for each sample, including known genotype controls and a no‐template control (NTC). Label 0.2‐ml PCR tubes for each sample, including known genotype controls and a no‐template control (NTC). 4Prepare two master mixes on ice: one for the T allele reaction and one for the C allele reaction. The final reaction volume for each PCR is 10 µl (9 µl master mix + 1 µl genomic DNA). a.T allele reaction (F3.1/R3)—per reaction: PCR buffer: 1×MgCl2: 1.0 mMdNTP mix: 0.2 mM IL33 F3.1 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U.b.C allele reaction (F3.2/R3)—per reaction: PCR buffer: 1×MgCl2: 1.5 mMdNTP mix: 0.2 mM IL33 F3.2 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. Prepare two master mixes on ice: one for the T allele reaction and one for the C allele reaction. The final reaction volume for each PCR is 10 µl (9 µl master mix + 1 µl genomic DNA). a.T allele reaction (F3.1/R3)—per reaction: PCR buffer: 1×MgCl2: 1.0 mMdNTP mix: 0.2 mM IL33 F3.1 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U.b.C allele reaction (F3.2/R3)—per reaction: PCR buffer: 1×MgCl2: 1.5 mMdNTP mix: 0.2 mM IL33 F3.2 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. a.T allele reaction (F3.1/R3)—per reaction: PCR buffer: 1×MgCl2: 1.0 mMdNTP mix: 0.2 mM IL33 F3.1 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. T allele reaction (F3.1/R3)—per reaction: PCR buffer: 1× PCR buffer: 1× MgCl2: 1.0 mM MgCl2: 1.0 mM dNTP mix: 0.2 mM dNTP mix: 0.2 mM IL33 F3.1 primer: 0.25 µM IL33 F3.1 primer: 0.25 µM IL33 R3 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. Taq DNA polymerase: 0.5 U. b.C allele reaction (F3.2/R3)—per reaction: PCR buffer: 1×MgCl2: 1.5 mMdNTP mix: 0.2 mM IL33 F3.2 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. C allele reaction (F3.2/R3)—per reaction: PCR buffer: 1× PCR buffer: 1× MgCl2: 1.5 mM MgCl2: 1.5 mM dNTP mix: 0.2 mM dNTP mix: 0.2 mM IL33 F3.2 primer: 0.25 µM IL33 F3.2 primer: 0.25 µM IL33 R3 primer: 0.25 µM IL33 R3 primer: 0.25 µM HGH forward primer: 0.1 µM HGH forward primer: 0.1 µM HGH reverse primer: 0.1 µM HGH reverse primer: 0.1 µM Taq DNA polymerase: 0.5 U. Taq DNA polymerase: 0.5 U. 5For each reaction, dispense 9 µl master mix into each tube and add 1 µl genomic DNA (30‐50 ng/µl). For each reaction, dispense 9 µl master mix into each tube and add 1 µl genomic DNA (30‐50 ng/µl). 6Run the following PCR program for both allele‐specific reactions: Initial step:15 min95°C30 cycles:30 s95°C30 s62°C30 s72°CFinal step:10 min72°CHold at 4°C.John Wiley & Sons, Ltd. Run the following PCR program for both allele‐specific reactions: Initial step:15 min95°C30 cycles:30 s95°C30 s62°C30 s72°CFinal step:10 min72°CHold at 4°C.John Wiley & Sons, Ltd. Initial step:15 min95°C30 cycles:30 s95°C30 s62°C30 s72°CFinal step:10 min72°CHold at 4°C.John Wiley & Sons, Ltd. 7Add 2.5 µl of 5× loading buffer to each reaction and load 6 µl of PCR product onto a 2% (w/v) agarose gel. Perform electrophoresis at 150 V, 300 mA, and 150 W for 10 min. Successful allele‐specific amplification is indicated by the presence of a 155‐bp amplicon, together with the internal control band. Interpret genotypes as described in the Understanding Results section (see Fig. 1). Add 2.5 µl of 5× loading buffer to each reaction and load 6 µl of PCR product onto a 2% (w/v) agarose gel. Perform electrophoresis at 150 V, 300 mA, and 150 W for 10 min. Successful allele‐specific amplification is indicated by the presence of a 155‐bp amplicon, together with the internal control band. Interpret genotypes as described in the Understanding Results section (see Fig. 1). Representative agarose gel electrophoresis profile of PCR‐SSP products for IL33 rs1929992 (T>C) genotyping. PCR amplicons were separated on a 2% agarose gel stained with SYBR Safe. (A) Amplification obtained using the T‐allele‐specific forward primer (F3.1). (B) Amplification obtained using the C‐allele‐specific forward primer (F3.2). LD indicates the 100‐bp DNA ladder. T/T, homozygous T; T/C, heterozygous; C/C, homozygous C; NTC, no‐template control. The 460‐bp fragment represents the coamplified human growth hormone (HGH) internal control, and the 155‐bp fragment corresponds to the rs1929992 allele‐specific amplification product. Sizes of DNA ladder fragments are shown in base pairs (bp) to verify expected amplicon size and electrophoretic migration. GENOMIC DNA EXTRACTION FROM WHOLE BLOOD BY THE SALTING‐OUT METHOD Genomic DNA is extracted from EDTA‐anticoagulated whole blood using the salting‐out method as originally described by John et al. (1991). This method provides a rapid, inexpensive, and organic‐solvent‐free approach for isolating high‐molecular‐weight genomic DNA suitable for downstream PCR‐based applications. The protocol described below follows the procedure reported in that study, with minor adaptations for sample volume and laboratory routine. All steps and reagent principles are derived from the original publication. Materials Whole blood collected in EDTA tubes Red blood cell lysis solution (10 mM Tris·Cl, pH 7.6/10 mM KCl/10 mM MgCl2; John et al., 1991)Nucleus lysis buffer: 10 mM Tris·Cl, pH 8.2/400 mM NaCl/2 mM EDTA (see Current Protocols, 2006, for stock solutions)Saturated NaCl solution100% ethanol or isopropanol, ice cold70% (v/v) ethanol Nuclease‐free water or TE buffer (Current Protocols, 2006) Microcentrifuge1.5‐ml microcentrifuge tubes2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tipsVortex mixer Additional reagents and equipment for DNA quantification (Gallagher & Desjardins, 2008) Whole blood collected in EDTA tubes Whole blood collected in EDTA tubes Red blood cell lysis solution (10 mM Tris·Cl, pH 7.6/10 mM KCl/10 mM MgCl2; John et al., 1991) Red blood cell lysis solution (10 mM Tris·Cl, pH 7.6/10 mM KCl/10 mM MgCl2; John et al., 1991) Nucleus lysis buffer: 10 mM Tris·Cl, pH 8.2/400 mM NaCl/2 mM EDTA (see Current Protocols, 2006, for stock solutions) Nucleus lysis buffer: 10 mM Tris·Cl, pH 8.2/400 mM NaCl/2 mM EDTA (see Current Protocols, 2006, for stock solutions) Saturated NaCl solution Saturated NaCl solution 100% ethanol or isopropanol, ice cold 100% ethanol or isopropanol, ice cold 70% (v/v) ethanol 70% (v/v) ethanol Nuclease‐free water or TE buffer (Current Protocols, 2006) Nuclease‐free water or TE buffer (Current Protocols, 2006) Microcentrifuge Microcentrifuge 1.5‐ml microcentrifuge tubes 1.5‐ml microcentrifuge tubes 2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tips 2‐ to 20‐µl, 20‐ to 200‐µl, and 100‐ to 1000‐µl adjustable micropipets and appropriate sterile‐filtered pipet tips Vortex mixer Vortex mixer Additional reagents and equipment for DNA quantification (Gallagher & Desjardins, 2008) Additional reagents and equipment for DNA quantification (Gallagher & Desjardins, 2008) 1Lyse erythrocytes by adding 5 ml red blood cell lysis solution to 5 ml whole blood and mixing gently.This step removes erythrocytes while preserving leukocyte nuclei. Lyse erythrocytes by adding 5 ml red blood cell lysis solution to 5 ml whole blood and mixing gently. This step removes erythrocytes while preserving leukocyte nuclei. 2Centrifuge 10 min at ∼700 × g, room temperature, and discard the supernatant to obtain the leukocyte pellet. Centrifuge 10 min at ∼700 × g, room temperature, and discard the supernatant to obtain the leukocyte pellet. 3Using a micropipet, resuspend the leukocyte pellet in 1 ml nucleus lysis buffer.This buffer stabilizes DNA and facilitates subsequent protein digestion. Using a micropipet, resuspend the leukocyte pellet in 1 ml nucleus lysis buffer. This buffer stabilizes DNA and facilitates subsequent protein digestion. 4Add 300 µl of saturated NaCl solution to the 1 ml of resuspended leukocytes and vortex vigorously to precipitate proteins.High salt concentration promotes aggregation and precipitation of proteins. Add 300 µl of saturated NaCl solution to the 1 ml of resuspended leukocytes and vortex vigorously to precipitate proteins. High salt concentration promotes aggregation and precipitation of proteins. 5Centrifuge 3‐5 min at ≥10,000 × g, room temperature, and transfer the supernatant to a clean tube. Centrifuge 3‐5 min at ≥10,000 × g, room temperature, and transfer the supernatant to a clean tube. 6Precipitate DNA by adding cold 100% ethanol or isopropanol and gently inverting the tube. Precipitate DNA by adding cold 100% ethanol or isopropanol and gently inverting the tube. 7Centrifuge to pellet DNA and discard supernatant. Centrifuge to pellet DNA and discard supernatant. 8Wash DNA pellet with 70% ethanol to remove residual salts. Wash DNA pellet with 70% ethanol to remove residual salts. 9Air‐dry the pellet briefly and resuspend in nuclease‐free water or TE buffer. Air‐dry the pellet briefly and resuspend in nuclease‐free water or TE buffer. 10Quantify DNA concentration and store at −20°C until use in Basic Protocol. Quantify DNA concentration and store at −20°C until use in Basic Protocol. COMMENTARY Critical Parameters Primer specificity Allele discrimination in PCR‐SSP depends primarily on primer design. For IL33 rs1929992, the polymorphic nucleotide must be positioned at the 3′ terminus of the allele‐specific forward primer (F3.1 for the T allele and F3.2 for the C allele). Because amplification occurs only when the terminal nucleotide is fully complementary to the target allele, even subtle mismatches or primer degradation may compromise specificity and result in weak or nonspecific amplification. Annealing temperature Using the optimized annealing temperature (62°C) is critical for maintaining selective amplification. Temperatures below this condition may increase nonspecific primer binding and false‐positive amplification, whereas higher temperatures may reduce amplification efficiency, particularly in samples with lower DNA concentration or quality. MgCl2 concentration Magnesium concentration strongly influences polymerase activity and primer‐template interactions. Optimal performance was achieved using 1.0 mM MgCl2 for the T allele reaction and 1.5 mM for the C allele reaction. Deviations from these concentrations may alter amplification specificity, band intensity, or reaction reproducibility. DNA quality and concentration High‐quality genomic DNA is required for reproducible amplification. DNA samples should ideally present an A 260/A 280 ratio of ∼1.8 and a concentration sufficient to provide 30‐50 ng DNA per reaction. Degraded DNA or residual contaminants may reduce amplification efficiency or produce inconsistent electrophoretic patterns. Troubleshooting Common problems encountered during PCR‐SSP genotyping of IL33 rs1929992 and their corresponding causes and solutions are summarized in Table 2. Table 2Troubleshooting Guide for PCR‐SSP Genotyping of IL33 rs1929992ProblemPossible causeSolutionAmplification in NTCReagent contaminationPrepare fresh reagents; replace aliquots; physically separate pre‐ and post‐PCR areas.No allele‐specific band (155 bp)Low DNA quality or insufficient DNAVerify DNA purity (A 260/A 280 ≈ 1.8) and concentration; repeat extraction if necessary.Weak amplificationSuboptimal MgCl2 concentrationReconfirm MgCl2 concentration according to allele‐specific reaction.Nonspecific bandsAnnealing temperature too lowIncrease annealing temperature or verify primer specificity.John Wiley & Sons, Ltd. Troubleshooting Guide for PCR‐SSP Genotyping of IL33 rs1929992 Understanding Results Representative electrophoretic patterns generated using the optimized PCR‐SSP assay for IL33 rs1929992 (T>C) genotyping are presented in Figure 1. Successful reactions produce a 460‐bp fragment corresponding to the co‐amplified human growth hormone (HGH) internal control. Presence of this fragment confirms reaction integrity, adequate DNA quality, and proper PCR performance. Allelic determination is based on amplification of a 155‐bp allele‐specific product. The T allele reaction, performed using the forward primer F3.1, produces amplification only when the rs1929992 T allele is present. Likewise, the C allele reaction, performed using primer F3.2, selectively amplifies samples carrying the C allele. Genotypes are assigned according to the following electrophoretic profile: ● 155‐bp band detected only in the T‐specific reaction → T/T genotype;● 155‐bp band detected only in the C‐specific reaction → C/C genotype;● 155‐bp band detected in both reactions → T/C genotype. ● 155‐bp band detected only in the T‐specific reaction → T/T genotype; ● 155‐bp band detected only in the T‐specific reaction → T/T genotype; ● 155‐bp band detected only in the C‐specific reaction → C/C genotype; ● 155‐bp band detected only in the C‐specific reaction → C/C genotype; ● 155‐bp band detected in both reactions → T/C genotype. ● 155‐bp band detected in both reactions → T/C genotype. The HGH internal control band must be detected in every valid reaction. Samples lacking the internal control band should be considered inconclusive and reanalyzed before genotype assignment. Figure 1A illustrates amplification profiles obtained in the T allele reaction, whereas Figure 1B shows amplification generated in the C allele reaction. Fragment size confirmation is provided by the 100‐bp DNA ladder (LD). No amplification should be observed in the no‐template control (NTC), confirming absence of reagent contamination. After assay optimization, specific amplification was consistently achieved using 1.0 mM MgCl2 for the T allele reaction, 1.5 mM MgCl2 for the C allele reaction, 62°C annealing temperature, and 30‐50 ng genomic DNA per reaction. Under these conditions, expected fragments appear as distinct and well‐defined bands without detectable nonspecific amplification, facilitating straightforward genotype interpretation. Analytical performance of the assay was assessed through comparison with Sanger sequencing, which demonstrated complete concordance with PCR‐SSP genotype assignments in representative validation samples. These findings support the reliability of allele‐specific amplification mediated by 3′‐terminal nucleotide complementarity. When carried out under the conditions described here, this protocol provides consistent and reproducible genotyping results suitable for population‐based analyses and genetic association studies involving IL33 rs1929992. Time Considerations Genomic DNA extraction: ∼3‐4 h. PCR amplification and electrophoresis: ∼4‐5 h. Total time per batch of 24 samples: ∼1 working day. Author Contributions Aléia Harumi Uchibaba Yamanaka: Conceptualization; investigation; writing—original draft; methodology; validation; writing—review and editing; visualization; data curation. Guilherme Castellani: Writing—original draft; writing—review and editing; investigation; methodology; data curation. Matheus Braga: Investigation; writing—review and editing; validation; formal analysis; data curation. Josiane Bazzo de Alencar: Investigation; writing—review and editing; writing—original draft; methodology; data curation. Letícia Cristina de Almeida Silva: Investigation; writing—review and editing; methodology; data curation. Quirino Alves de Lima Neto: Investigation; funding acquisition; writing—original draft; methodology; writing—review and editing; project administration; data curation; supervision; resources. Conflict of Interest The authors declare no commercial or financial relationships that could be construed as a potential conflict of interest.